Abstract
This study aimed to identify changes in the level of neuropeptides among current smokers, former smokers, and individuals who had never smoked, and how smoking habits affect obesity and metabolic syndrome (MetS). Neuropeptide levels, anthropometric parameters, and metabolic syndrome diagnostic indices were determined among male workers; 117 of these had never smoked, whereas 58 and 198 were former and current smokers, respectively. The total sample comprised 373 male workers. The results obtained from anthropometric measurements showed that current smokers attained significantly lower body weight, body mass index, waist circumference, and abdominal fat thickness values than former smokers and those who had never smoked. Current smokers’ eating habits proved worse than those of non-smokers and individuals who had never smoked. The level of brain-derived neurotrophic factor (BDNF) in the neuropeptides in the case of former smokers was 23.6 ± 9.2 pg/ml, higher than that of current smokers (20.4 ± 6.1) and individuals who had never smoked (22.4 ± 5.8) (F = 6.520, p = 0.002). The level of adiponectin among former smokers was somewhat lower than that of current smokers, whereas leptin levels were higher among former smokers than current smokers; these results were not statistically significant. A relationship was found between adiponectin and triglyceride among non-smokers (odds ratio = 0.660, β value = −0.416, p < 0.01) and smokers (odds ratio = 0.827, β value = −0.190, p < 0.05). Further, waist circumference among non-smokers (odds ratio = 1.622, β value = 0.483, p < 0.001) and smokers (odds ratio = 1.895, β value = 0.639, p < 0.001) was associated with leptin. It was concluded that cigarette smoking leads to an imbalance of energy expenditure and appetite by changing the concentration of neuropeptides such as adiponectin, BDNF, leptin, and hsCRP, and influences food intake, body weight, the body mass index, blood pressure, and abdominal fat, which are risk factors for MetS and cardiovascular disease.
Article PDF
Similar content being viewed by others
References
WHO. (2009) WHO report on the global tobacco epidemic, 2009-Implementing smoke-free environments. WHO, Geneva, pp. 1–568.
Finucane, M.M., Stevens, G.A., Cowan, M.J., Danaei, G., Lin, J.K., Paciorek, C.J., Singh, G.M., Gutierrez, H.R., Lu, Y., Bahalim, A.N., Farzadfar, F., Riley, L.M. and Ezzati, M. (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet, 377, 557–567.
Ma, J., Jemal, A., Flanders, W.D. and Ward, E.M. (2013) Joint association of adiposity and smoking with mortality among U.S. adults. Prev. Med., 56, 178–184.
Chrostowska, M., Szyndler, A., Hoffmann, M. and Narkiewicz, K. (2013) Impact of obesity on cardiovascular health. Best Pract. Res. Clin. Endocrinol. Metab., 27, 147–156.
Lee, H., Joe, K.H., Kim, W., Park, J., Lee, D.H., Sung, K.W. and Kim, D.J. (2006) Increased leptin and decreased ghrelin level after smoking cessation. Neurosci. Lett., 409, 47–51.
von der Goltz, C., Koopmann, A., Dinter, C., Richter, A., Rockenbach, C., Grosshans, M., Nakovics, H., Wiedemann, K., Mann, K., Winterer, G. and Kiefer, F. (2010) Orexin and leptin are associated with nicotine craving: A link between smoking, appetite and reward. Psychoneuroendocrinology, 35, 570–577.
Lebrun, B., Bariohay, B., Moyse, E. and Jean, A. (2006) Brain-derived neurotrophic factor (BDNF) and food intake regulation: A minireview. Auton. Neurosci., 126, 30–38.
Elbatarny, H.S., Netherton, S.J., Ovens, J.D., Ferguson, A.V. and Maurice, D.H. (2007) Adiponectin, ghrelin, and leptin differentially influence human platet and human vascular endothelial cell functions: Implication in obesity-associated cardiovascular diseases. Eur. J. Pharmacol., 558, 7–13.
Lee, G.H., Proenca, R., Montez, J.M., Carroll, K.M., Darvishzadeh, J.G., Lee, J.I. and Friedman, J.M. (1996) Abnomal splicing of the leptin receptor in diabetic mice. Nature, 379, 632–635.
Kadowaki, T., Yamauch, T. and Kubota, N. (2008) The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett., 582, 74–80.
Ahima, R.S. (2005) Central actions of adipocytes hormones. Trends Endocrinol. Metab., 16, 307–313.
Lam, K.S. and Xu, A. (2005) Adiponectin: protectionof the endothelium. Curr. Diabetes Rep., 5, 254–259.
Silha, J.V., Krsek, M., Skrha, J.V., Sucharda, P., Nyomba, B.L. and Murphy, L.J. (2003) Plasma resistin, adiponectin and leptin level in lean and obese subjects: correlation with insulin resistance. Eur. J. Endocrinol., 149, 331–335.
Davies, A.M. (1994) The role of neurotrophins in the developing nervous system. J. Neurobiol., 25, 1334–1348.
McAllister, A.K. (2001) Neurotrophins and neuronal differentiation in the central nervous system. Cell. Mol. Life Sci., 58, 1054–1060.
Billes, S.K., Simonds, S.E. and Cowley, M.A. (2012) Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism. Mol. Metab., 1, 86–93.
Wager-Srdar, S.A., Levine, A.S., Morley, J.E., Hoidal, J.R. and Niewoehner, D.E. (1984) Effects of cigarette smoke and nicotine on feeding and energy. Physiol. Behav., 32, 389–395.
Li, M.D. and Kane, J.K. (2003) Effects of nicotine on the expression of leptin and forebrain leptin receptors in the rat. Brain Res., 991, 222–231.
Kim, T.S., Kim, D.J., Lee, H. and Kim, Y.K. (2007) Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci. Lett., 423, 53–57.
Otsuka, F., Kojima, S., Maruyoshi, H., Kojima, S., Matsuzawa, Y., Funahashi, T., Kaikita, K., Sugiyama, S., Kimura, K., Umemura, S. and Ogawa, H. (2009) Smoking cessation is associated with increased plasma adiponectin levels in men. J. Cardiol., 53, 219–225.
National Cholesterol Education Program’s Adult Treatment Panel III report (NCEP-ATP III). (2002) Third report of the National Cholesterol Education Program expert panel on detection, evaluation, and tratment of high blood cholesterol in alduts(Adults Treatment Panel III) final report. Circulation, 106, 3143–3421.
Piasecki, T.M. (2006) Relapse smoking. Clin. Psychol. Rev., 26, 196–215.
Frankish, H.M., Dryden, S., Wang, Q., Bing, C., MacFarlane, I.A. and Williams, G. (1995) Nicotine administration reduces neuropeptide Y and neuropeptide mRNA concentration in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance. Brain Res., 694, 139–146.
Grunberg, N.E., Bowen, D.J. and Winders, H.E. (1986) Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology (Berl), 90, 101–105.
Morgan, T.M., Crawford, L., Stoller, A., Toth, D., Yeo, K.T. and Baron, J.A. (2004) Acute effects of nicotine on serum glucose, insulin, growth hormone, and cortisol in healthy smokers. Metabolism, 53, 578–582.
Arora, S. and Anubhuti, A.S. (2006) Role of neuropeptides in appetite regulation and obesity a review. Neuropeptides, 40, 375–401.
Hillemacher, T., Weinland, C., Heberlein, A., Gröschl, M., Schanze, A., Frieling, H., Wilhelm, J., Kornhuber, J. and Bleich, S. (2009) Increased levels of adiponectin and resistin in alcohol dependence-possible link to craving. Drug Alcohol Depend., 99, 333–337.
Iwashma, Y., Katsuya, T., Ishikawa, K., Kida, I., Ohishi, M., Horio, T., Ouchi, N., Ohashi, K., Kihara, S., Funahashim, T., Rakugim, H. and Ogiharam, T. (2005) Association of hypoadiponectinemia with smoking habit in man. Hypertension, 45, 1094–1100.
Kivinummi, T., Kaste, K., Rantamaki, T., Castrén, E. and Ahtee, L. (2011) Alterations in BDNF and phosphor-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice. Neurosci. Lett., 491, 108–112.
Laviolette, S.R. and van der Kooy, D. (2004) The neurobiology of nicotine addiction: bridging the gap from molecules to behavior. Nat. Rev. Neurosci., 5, 55–65.
Kenny, P.J., File, S.E. and Rattray, M. (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotophic factor mRNA in rat hippocampus. Brain Res. Mol. Brain Res., 85, 234–238.
Pu, L., Liu, Q.S. and Poo, M.M. (2006) BDNF-dependent synaptic sensitization in midbrain dopamine neurons after cocaine withdrawal. Nat. Neurosci., 9, 605–607.
Caan, B., Coates, A., Schaefer, C., Finkler, L., Sternfeld, B. and Corbett, K. (1996) Women gain weight 1 year after smoking cessation while dietary intake temporarily increases. J. Am. Diet. Assoc., 96, 1150–1155.
Kamohara, S., Burcelin, R., Halaas, J.L., Friedman, J.M. and Charron, M.J. (1997) Acute stimulation of glucose metabolism in mice by leptin treatment. Nature, 389, 374–377.
Kim, K.W., Heo, K.H., Won, Y.L., Ko, K.S., Kim, T.G., Lee, M.Y., Park, J. and Park, S.G. (2009) Overweight of Korean male workers and genetic polymorphism of insulin receptor substrate 1(IRS1) gene. Anim. Cells Syst., 13, 127–132.
Lee, I.T., Lee, W.J., Tsai, I.C., Liang, K.W., Lin, S.Y., Wan, C.J., Fu, C.P. and Sheu, W.H. (2012) Brain-derived neurotrophic factor not associated with metabolic syndrome but inversely correlated with vascular cell adhesion molecule-1 in men without diabetes. Clin. Chim. Acta, 413, 944–948.
Lieb, W., Sullivan, L.M., Harris, T.B., Roubenoff, R., Benjamin, E.J., Levy, D., Fox, C.S., Wang, T.J., Wilson, P.W., Kannel, W.B. and Vasan, R.S. (2009) Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals. Diabetes Care, 32, 612–616.
Zhuo, Q., Wang, Z., Fu, P., Piao, J., Tian, Y., Xu, J. and Yang, X. (2009) Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res. Clin. Pract., 84, 27–33.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, KW., Won, Y.L., Ko, K.S. et al. Smoking Habits and Neuropeptides: Adiponectin, Brain-derived Neurotrophic Factor, and Leptin Levels. Toxicol Res. 30, 91–97 (2014). https://doi.org/10.5487/TR.2014.30.2.091
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2014.30.2.091